CD47 blockade declines lymphoma metastasis to the brain, pituitary gland, nasal cavity, bone marrow, pancreas, kidney, and liver, dramatically, through augmenting the phagocytosis of macrophages since CD47 expression depicts an increase in metastatic and disseminated lymphoma in comparison to primary lesions. This evidence concerns the gene CD47 and lymphoma.